SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-22-034072
Filing Date
2022-09-20
Accepted
2022-09-20 17:09:19
Documents
16

Document Format Files

Seq Description Document Type Size
1 425 brhc10042079_425.htm 425 68945
2 image01.jpg GRAPHIC 245214
3 image02.jpg GRAPHIC 395443
4 image03.jpg GRAPHIC 410275
5 image04.jpg GRAPHIC 431476
6 image05.jpg GRAPHIC 393664
7 image06.jpg GRAPHIC 322738
8 image07.jpg GRAPHIC 416367
9 image08.jpg GRAPHIC 377302
10 image09.jpg GRAPHIC 376956
11 image10.jpg GRAPHIC 401772
12 image11.jpg GRAPHIC 336369
13 image12.jpg GRAPHIC 368185
14 image13.jpg GRAPHIC 391846
15 image14.jpg GRAPHIC 372537
16 image15.jpg GRAPHIC 30142
  Complete submission text file 0001140361-22-034072.txt   7332096
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filed by) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 BROADWAY SUITE 310 CAMBRIDGE MA 02139
Business Address 201 BROADWAY SUITE 310 CAMBRIDGE MA 02139 610-424-2650
Renovacor, Inc. (Subject) CIK: 0001799850 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39271 | Film No.: 221254427
SIC: 2836 Biological Products, (No Diagnostic Substances)